End-of-day quote
Shanghai S.E.
18:00:00 2024-05-15 EDT
|
5-day change
|
1st Jan Change
|
11.27
CNY
|
+1.26%
|
|
-2.93%
|
-45.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,806
|
4,740
|
4,092
|
1,933
|
871
|
871
|
-
|
Enterprise Value (EV)
1 |
2,806
|
4,740
|
4,092
|
1,933
|
1,611
|
871
|
871
|
P/E ratio
|
42.7
x
|
59
x
|
62.3
x
|
-250
x
|
-209
x
|
15.9
x
|
7.94
x
|
Yield
|
0.55%
|
0.52%
|
-
|
-
|
-
|
4.08%
|
4.44%
|
Capitalization / Revenue
|
10.5
x
|
15.1
x
|
-
|
9.49
x
|
4.85
x
|
1.5
x
|
1.16
x
|
EV / Revenue
|
10.5
x
|
15.1
x
|
-
|
9.49
x
|
4.85
x
|
1.5
x
|
1.16
x
|
EV / EBITDA
|
37.1
x
|
45.3
x
|
-
|
65.8
x
|
39.3
x
|
6.34
x
|
3.89
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.37
x
|
5.29
x
|
-
|
2.1
x
|
1.76
x
|
0.9
x
|
0.8
x
|
Nbr of stocks (in thousands)
|
77,284
|
77,284
|
77,284
|
77,284
|
77,284
|
77,284
|
-
|
Reference price
2 |
36.31
|
61.33
|
52.95
|
25.01
|
11.27
|
11.27
|
11.27
|
Announcement Date
|
2/26/20
|
2/26/21
|
2/25/22
|
2/27/23
|
2/23/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
248.3
|
268.1
|
314.1
|
-
|
203.8
|
332.3
|
581.5
|
751.2
|
EBITDA
1 |
-
|
75.63
|
104.6
|
-
|
29.4
|
40.98
|
137.4
|
223.9
|
EBIT
1 |
-
|
56.56
|
81.26
|
-
|
-18.97
|
-15.22
|
61.97
|
125.7
|
Operating Margin
|
-
|
21.1%
|
25.87%
|
-
|
-9.31%
|
-4.58%
|
10.66%
|
16.74%
|
Earnings before Tax (EBT)
1 |
-
|
58.41
|
85.15
|
-
|
-19.1
|
-14.64
|
62.97
|
126.2
|
Net income
1 |
-
|
51.44
|
80.02
|
65.82
|
-7.837
|
-7.699
|
95.95
|
146.2
|
Net margin
|
-
|
19.19%
|
25.47%
|
-
|
-3.85%
|
-2.32%
|
16.5%
|
19.47%
|
EPS
2 |
-
|
0.8500
|
1.040
|
0.8500
|
-0.1000
|
-0.1000
|
0.7100
|
1.420
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2000
|
0.3200
|
-
|
-
|
-
|
0.4600
|
0.5000
|
Announcement Date
|
10/15/19
|
2/26/20
|
2/26/21
|
2/25/22
|
2/27/23
|
2/23/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
12.2%
|
9.27%
|
-
|
-0.84%
|
-0.84%
|
5.64%
|
10%
|
ROA (Net income/ Total Assets)
|
-
|
6.24%
|
7%
|
-
|
-0.55%
|
2.86%
|
6.63%
|
6.62%
|
Assets
1 |
-
|
823.9
|
1,143
|
-
|
1,436
|
2,036
|
1,448
|
2,209
|
Book Value Per Share
2 |
-
|
10.80
|
11.60
|
-
|
11.90
|
11.90
|
12.60
|
14.10
|
Cash Flow per Share
2 |
-
|
0.2600
|
0.4300
|
-
|
0.9300
|
0.1000
|
3.500
|
2.660
|
Capex
1 |
-
|
42.6
|
89.1
|
-
|
242
|
89.4
|
499
|
237
|
Capex / Sales
|
-
|
15.9%
|
28.36%
|
-
|
118.64%
|
26.92%
|
85.76%
|
31.6%
|
Announcement Date
|
10/15/19
|
2/26/20
|
2/26/21
|
2/25/22
|
2/27/23
|
2/23/24
|
-
|
-
|
Last Close Price
11.27
CNY Average target price
20.45
CNY Spread / Average Target +81.46% Consensus |
1st Jan change
|
Capi.
|
---|
| -45.95% | 119M | | +5.09% | 106B | | -3.11% | 63.67B | | +74.29% | 49.32B | | +15.53% | 38.56B | | +5.11% | 32.65B | | +10.79% | 20.08B | | +13.07% | 17.01B | | +18.38% | 15.41B | | +4.83% | 14.41B |
Other Commodity Chemicals
|